For the year ending 2025-12-31, CURX has $11,580,124 in assets. $361,040 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 4,973,134 | |||
| Prepaid expenses | 6,254,374 | |||
| Total current assets | 11,227,508 | |||
| Right-of-use asset | 352,616 | |||
| Total assets | 11,580,124 | |||
| Accrued expenses | 11,915 | |||
| Accounts payable | 2,426 | |||
| Lease liability, current | 122,689 | |||
| Total current liabilities | 137,030 | |||
| Lease liability, noncurrent | 224,010 | |||
| Total liabilities | 361,040 | |||
| Common stock, 475,000,000 shares authorized 0.0001 par value 28,340,812 shares issued and outstanding as of december 31, 2025, and 24,000,000 december 31, 2024 | 2,834 | |||
| Preferred stock, 25,000,000 shares authorized 0.0001 par value 1,000,000 shares issued and outstanding as of december 31, 2025, and december 31, 2024 | 100 | |||
| Additional paid-in capital | 16,063,705 | |||
| Accumulated deficit | -4,847,555 | |||
| Total shareholders equity | 11,219,084 | |||
| Total liabilities and shareholders equity | 11,580,124 | |||
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (CURX)